Cargando…
Applying Metabolomics to Understand the Aggressive Phenotype and Identify Novel Therapeutic Targets in Glioblastoma
Glioblastoma continues to be an invariably fatal malignancy. The established approach for understanding the biology of these aggressive tumors in an effort to identify novel molecular targets has largely been genotype-based. Unfortunately, clinical gains offered by this level of understanding have b...
Autores principales: | Ahmed, Kamran A., Chinnaiyan, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192690/ https://www.ncbi.nlm.nih.gov/pubmed/25167383 http://dx.doi.org/10.3390/metabo4030740 |
Ejemplares similares
-
Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma
por: Flor, Susanne, et al.
Publicado: (2021) -
The radiosensitivity index predicts for overall survival in glioblastoma
por: Ahmed, Kamran A., et al.
Publicado: (2015) -
Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
por: Schmid-Alliana, Annie, et al.
Publicado: (2018) -
Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs
por: Georgescu, Maria-Magdalena, et al.
Publicado: (2021) -
Targeting the Unfolded Protein Response in Glioblastoma Cells with the Fusion Protein EGF-SubA
por: Prabhu, Antony, et al.
Publicado: (2012)